Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocuphire Pharma Inc (NQ: OCUP )

1.290 +0.030 (+2.38%)
Streaming Delayed Price Updated: 10:45 AM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,675
Open 1.260
Bid (Size) 1.290 (15)
Ask (Size) 1.300 (15)
Prev. Close 1.260
Today's Range 1.250 - 1.310
52wk Range 1.150 - 3.756
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist. 
Via Talk Markets

Performance

YTD
-57.98%
-57.98%
1 Month
+8.40%
+8.40%
3 Month
-16.77%
-16.77%
6 Month
-40.83%
-40.83%
1 Year
-64.56%
-64.56%

More News

Read More
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Ocuphire Pharma Q3 Earnings
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
Via InvestorPlace
3 Value Stocks to Buy on the Dip: February 2024
Via InvestorPlace
Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Surprise! These 3 Penny Stocks Pack Powerful Financials.
Via InvestorPlace
The 7 Best Stocks Under $10 to Buy in May
Via InvestorPlace
7 Small-Cap Biotech Stocks with Massive Potential
Via InvestorPlace
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case
Via Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
Via Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.